Member Info for Sonnets

What happened to the considered Fund Management Division Sale as flagged up in December?

Is someone or something hoovering up TRX shares in the background?

I suspect so.

Smacks that was £18m sterling not £22m . Enough I believe DDDD said to cover costs to August. Myrck were obliged to by in to the tune of. $5m

YB. Noted.
Annoying though that today more shares bought than sold and price drift S. Twould be nice to see this in the News or on a leaderboard if only to impart we at NFX are progressing in this New World pandemic

Details mate

Well and truly positioned. GO ODX.

Excellent News and progress. Act has got it together. Well done on further US Government injection

Are any patients in the SNG current phase 2 trial sourced in London currently?

Thanks in advance

Nice post Bunco. Quite persuasive.

One cannot deny though that what this company needs is a move N in its share Price. It is languishing badly . People are tempted to swallow their losses, take bitter medicine and chase it back elsewhere.

They say that Shakespeare tended to introduce his best characters late in plays. Maybe Dan , in this Biopharma boom time is taking that tact.

Personally, I would like an Update. Sitting on a lot of shares and have been for a long time. JJW's point on the subject is well put

Stunned that TRX in short order and a UK company at that , landed the US money so quickly.It suggests inter alia that TRX is attractive to the US. The application would have shown cashflow and available capital. A glance (due diligence) would permit a view that all might expire without funding, or be diluted with funding. Yet money was rapidly found. I wonder where this might lead, and if boom time could happen quickly and without warning.

Serious Q. I hold here.

Is a Fund raise on the horizon?

I like the update. Revenues increased Husbandry enhanced by a 629000 dollar US injection that does not look like it needs to be repaid. (UK government take note thats how you do it). Money already received and runway cleared to 2nd week of July enabling clear heads to take best option forward.

SP will be favourably impacted. Super company with irons across UK, US & Germany. I wouldn't be suprised to see 2p shortly and perhaps a major US investment down the road.

MY thoughts. GLA

Super FDA approved product in its armoury, this will going considerably N of here in my view. Couldnt even buy 15000 online just now. Go figure

About time that NFX re-rated. So much going for it. And it's in the COPD field with NXP0002.

I would not be surprised to see a renegotiation of the terms of the MidCap current funding in favour of TRX and/or an equity buy in (or stake/ position being taken by a third party). TRX is brimful of potential and is cashflow generative.

Just my opinion but the above as a scenario works and is doable in my view.

As to the slight drop this morning, Its Easter. Although that said I would not be stunned to see a spike N this pm

Peace and safety to one and all

Serious Q. How is this developing. The rise of SNG shows just how useful an inhaler delivered treatment for COPD is deemed to be.

NFX raised money to drive development of its said drug in November. Over 4 months on. Update anyone?

Entirely sensible to cut adrift deadwood. Focus on gain going forward not avoidable losses. SP fall ridiculous in my view

Debt raising is a clear option as TRX is revenue productive and increasingly so. A Placing would not necessarily be at a discount. Given the net asset value c 5p + per share it might be at par or a premium. The latter particularly if coupled with some new debt.

There may even be some FED assistance available. Others might advise on that please.

I have increased my holding recently and happy that I did. News no doubt shortly.

DYOR

Sandhopper. You still can